ES460686A1 - Un procedimiento para la preparacion de 5-m-tolioxiuracilo. - Google Patents

Un procedimiento para la preparacion de 5-m-tolioxiuracilo.

Info

Publication number
ES460686A1
ES460686A1 ES460686A ES460686A ES460686A1 ES 460686 A1 ES460686 A1 ES 460686A1 ES 460686 A ES460686 A ES 460686A ES 460686 A ES460686 A ES 460686A ES 460686 A1 ES460686 A1 ES 460686A1
Authority
ES
Spain
Prior art keywords
tolyloxyuracil
ulcer agent
ulcer
agent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460686A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES460686A1 publication Critical patent/ES460686A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un procedimiento para la preparación de 5-m-toliloxiuracilo de la fórmula **fórmula** en su forma ceto o en su forma enol, así como de sus sales farmacéuticamente aceptables, caracterizado porque comprende las operaciones de hacer reaccionar 5-(m-toliloxi)-2- tiouracilo con una cantidad equivalente o en exceso de un ácido alfa-halogeno acético, hidrolizar el producto resultante de la reacción anterior en un ácido mineral acuoso , y aislar el producto de hidrólisis resultantes antes o después de convertirlo opcionalmente en una sal farmacéuticamente aceptable del mismo
ES460686A 1976-07-16 1977-07-13 Un procedimiento para la preparacion de 5-m-tolioxiuracilo. Expired ES460686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
ES460686A1 true ES460686A1 (es) 1978-12-01

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
ES460686A Expired ES460686A1 (es) 1976-07-16 1977-07-13 Un procedimiento para la preparacion de 5-m-tolioxiuracilo.

Country Status (29)

Country Link
US (1) US4080454A (es)
JP (1) JPS5337673A (es)
AR (1) AR213652A1 (es)
AT (1) AT351561B (es)
BE (1) BE856710A (es)
CA (1) CA1061788A (es)
CH (1) CH622512A5 (es)
CS (1) CS212264B2 (es)
DD (1) DD131556A5 (es)
DE (1) DE2731736A1 (es)
DK (1) DK139029B (es)
EG (1) EG12762A (es)
ES (1) ES460686A1 (es)
FI (1) FI772183A (es)
FR (1) FR2358399A1 (es)
GB (1) GB1542178A (es)
GR (1) GR68686B (es)
HU (1) HU177713B (es)
IL (1) IL52409A (es)
LU (1) LU77764A1 (es)
NL (1) NL7707729A (es)
NO (1) NO772489L (es)
PH (1) PH13190A (es)
PL (1) PL103783B1 (es)
PT (1) PT66808B (es)
SE (1) SE421125B (es)
SU (1) SU673169A3 (es)
YU (1) YU171677A (es)
ZA (1) ZA773927B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
JP5113752B2 (ja) 2005-08-22 2013-01-09 メリオール・ファーマスーティカルズ・ワン・インコーポレイテッド Lynキナーゼの活性を調節し、関連する疾患を治療するための方法および製剤
EP2120581A4 (en) * 2007-02-20 2011-03-16 Melior Pharmaceuticals I Inc METHODS OF IDENTIFYING LYN KINASE ACTIVATORS
BRPI0813167A2 (pt) * 2007-07-23 2014-12-23 Melior Discovery Inc Usos de uma composição e de um agente para modular a atividade e/ou a expressão de irs-1 e/ou akt, e, composto
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
CN110785170B (zh) 2017-04-10 2023-03-28 梅里奥尔医药I公司 脂肪细胞的治疗
WO2019164799A1 (en) 2018-02-21 2019-08-29 Melior Pharmaceuticals I, Inc. Treatment of liver diseases

Also Published As

Publication number Publication date
YU171677A (en) 1982-06-30
ZA773927B (en) 1978-05-30
JPS5337673A (en) 1978-04-06
NO772489L (no) 1978-01-17
FR2358399A1 (fr) 1978-02-10
CH622512A5 (es) 1981-04-15
PH13190A (en) 1980-01-16
AR213652A1 (es) 1979-02-28
PT66808A (en) 1977-08-01
HU177713B (en) 1981-12-28
IL52409A (en) 1979-11-30
SE421125B (sv) 1981-11-30
DK139029B (da) 1978-12-04
JPS5512017B2 (es) 1980-03-29
PL103783B1 (pl) 1979-07-31
DE2731736A1 (de) 1978-01-26
AT351561B (de) 1979-08-10
CA1061788A (en) 1979-09-04
NL7707729A (nl) 1978-01-18
EG12762A (en) 1979-12-31
IL52409A0 (en) 1977-08-31
GR68686B (es) 1982-02-01
LU77764A1 (es) 1978-02-02
CS212264B2 (en) 1982-03-26
SU673169A3 (ru) 1979-07-05
ATA509277A (de) 1979-01-15
BE856710A (fr) 1978-01-11
SE7707471L (sv) 1978-01-17
PL199633A1 (pl) 1978-04-10
DD131556A5 (de) 1978-07-05
DK139029C (es) 1979-05-07
FR2358399B1 (es) 1980-10-17
AU2663877A (en) 1978-05-18
DK318177A (es) 1978-01-17
FI772183A (es) 1978-01-17
PT66808B (en) 1978-12-21
GB1542178A (en) 1979-03-14
US4080454A (en) 1978-03-21

Similar Documents

Publication Publication Date Title
ES460686A1 (es) Un procedimiento para la preparacion de 5-m-tolioxiuracilo.
JPS51128827A (en) A stool for the aged and the physically andicapped
IL51863A0 (en) Agent for the prophylaxis and therapy of gastroenteritis
JPS53135768A (en) Face treating apparatus
JPS5210082A (en) Semiconductor device
ES436339A1 (es) Un metodo de preparar aminas terciarias.
JPS53149707A (en) Am-ssb common-use transmitter-receiver
JPS53127832A (en) Antiphkogistics for oral administration containing thiaprostaglandins
JPS5212097A (en) Corner abutment and method of manufacturing the same
JPS5276812A (en) Two-wire-type full duplex telecommunication
JPS53755A (en) Beauty device
JPS5227955A (en) Gear reduction device
JPS534649A (en) Apparatus for facial treatment
JPS533534A (en) Local anesthetics
JPS5295216A (en) Camera body of excellent maneuverability
MTP785B (en) Gymnastic-training recreative tool,adapted to promote the development of arm and shoulder masculature
JPS5231444A (en) Device for contrlling elevator
JPS5214908A (en) Capacity controlling device in screw compressor
CA641436A (en) Smoker's pipe holster
JPS53149441A (en) Cosmetic device
JPS51140128A (en) Inverter
JPS51124995A (en) Coin counter
JPS5286766A (en) Pulse counting timer
ES448550A1 (es) Procedimiento para preparar colest-5-enos 6- aminometilados y 3-oxigenados.
JPS5226684A (en) Suspender-supporter of suspension polisher